EOLS

Evolus Stock Analysis

AI Rating

Fair
  • Quality0/10
  • Growth 5/10
  • Value 3/10
Evolus sales and earnings growth
EOLS Growth
Neutral
  • Revenue Y/Y 11.61%
  • EPS Y/Y 1.23%
  • FCF Y/Y -122.23%
Evolus gross and profit margin trends
EOLS Profitability
Good
  • Gross margin 66.30%
  • EPS margin -17.40%
  • ROIC 5Y -35.44%
Evolus net debt vs free cash flow
EOLS Risk
Poor
  • Debt / Equity 999.0
  • Debt / FCF 2.0
  • Interest coverage -1.6

Evolus stock volatility is in-line with the overall market. We give it a Poor risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗